Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
How Heritage Commerce HTBK balances short term and long term focus HTBK Heritage Commerce Q4 2025 Earnings EPS Miss Expense Concerns CETX Cemtrex shares rise 431 percent despite Q3 2024 EPS miss as revenue grows 144 percent year over year How Tamboran TBN guidance shapes future expectations Q1 2026 EPS Misses Views Sabre Corporation SABR Stock Overnight Trade Modest Decline 20260420 Should I sell USDrugAcqII DMIIU stock Emerson Electric Co XLI 2026 Wall Street Outlook Balancing NearTerm Headwinds and LongTerm Upside The competitive edge that makes Crit Metals CRML special Tumbles Hard 20260508 How SIBONE SIBN earnings track against industry trends Q4 2025 Earnings Beat Estimates TACHW Titan management outlines key strategic priority of pursuing highgrowth tech acquisition targets this year Dogness DOGZ Drops 508 Key Support at 106 20260518 Orkla India Reports 75 Rise in Q4 PAT to 74 Crore Digital Commerce Surges 23 Amid Kerala Disruption ARS Pharmaceuticals SPRY Down 215 How Low Could It Go 20260518 Farmer FARM Q1 2026 Earnings Miss EPS 022 vs 009 Expected US Government Allocates 2 Billion to Boost Quantum Computing Sector Ryanair Reports Record Annual Profit but Withholds Forward Outlook ADP Private Payrolls Rise 109000 in April Exceeding Expectations AEON Bio AEON Q4 2025 Results Fall Short EPS 042 Revenue NA SpaceX Scrubs Starship Test Flight Reschedules for Friday Amid V3 Debut BlockCon Punta Cana Unites Web3 iGaming and Finance Leaders at Global Business Retreat HDFC Bank Shares Dip After Report on 45 Crore Camouflaged Payments CEO Reappointment Seen Unaffected Perpetua Resources Secures 29B US Loan for Idaho Critical Minerals Project GitHub Outages and Rival Tools Challenge Microsofts AI Coding Ambitions China Urges APEC Cooperation as Minister Skips Opening Session Due to Urgent Official Business DOC Q1 2026 Earnings Staggering EPS Beat Highlights Strong Portfolio Performance Upstream Bio Inc UPB Q1 2026 Earnings Narrowed Loss Per Share as Clinical Pipeline Advances WMK Q3 2023 Earnings Reported EPS of 086 with Modest Stock Response SVRA Q1 2026 Earnings Wider Loss Amid Continued Pipeline Development SES AI Q1 2026 Earnings EPS Misses Estimates as Company Continues RD Focus Immix Biopharma IMMX Edges Lower in Consolidation Phase Eyes Key Support at 829 Journey Medical DERM Holds Steady at 596 as Stock Consolidates Between Key Levels Dianthus Therapeutics DNTH Surges 437 as Stock Nears Key Resistance Level Presurance Holdings Notes PRHIZ Steady at 1744 as Market Weighs Credit and Rate Risks